Skip to main content
Clinical & Translational Immunology logoLink to Clinical & Translational Immunology
. 2021 Aug 11;10(8):e1331. doi: 10.1002/cti2.1331

Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma

Michael P Brown, Lisa M Ebert, Tessa Gargett
PMCID: PMC8357535  PMID: 34401149

Correction to:Clin Trans Immunol 2019; 8: e1050. doi: https://doi.org/10.1002/cti2.1050. Published online 20 May 2019.

The authors inadvertently excluded a funding body in the Acknowledgments section. The corrected version appears below:

ACKNOWLEDGMENTS

We acknowledge support from the Cancer Council SA Beat Cancer Project Hospital Research Support Package, a Cancer Council Early Career Research Fellowship, the Health Services Charitable Gifts Board (Adelaide) and The Hospital Research Foundation.

The authors apologise for this error.


Articles from Clinical & Translational Immunology are provided here courtesy of Australasian Society of Immunology

RESOURCES